Silexion Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLXN and other ETFs, options, and stocks.About SLXN
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
SLXN Key Statistics
Stock Snapshot
The current Silexion Therapeutics(SLXN) stock price is $1.42, with a market capitalization of 4.73M. The stock trades at a price-to-earnings (P/E) ratio of -0.11.
On 2026-03-26, Silexion Therapeutics(SLXN) stock traded between a low of $1.30 and a high of $1.42. Shares are currently priced at $1.42, which is +9.2% above the low and 0.0% below the high.
The Silexion Therapeutics(SLXN)'s current trading volume is 38.37K, compared to an average daily volume of 50.38K.
In the last year, Silexion Therapeutics(SLXN) shares hit a 52-week high of $22.36 and a 52-week low of $1.07.
In the last year, Silexion Therapeutics(SLXN) shares hit a 52-week high of $22.36 and a 52-week low of $1.07.
SLXN News
An update from Silexion Therapeutics ( (SLXN) ) is now available. On March 25, 2026, Silexion Therapeutics Corp. announced that its Board of Directors unanimou...
Silexion Therapeutics ( (SLXN) ) has provided an announcement. On March 23, 2026, Silexion Therapeutics reconvened an extraordinary general meeting originally...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.